Cargando…
RNAi-Based Gene Therapy Rescues Developmental and Epileptic Encephalopathy in a Genetic Mouse Model
Developmental and epileptic encephalopathy (DEE) associated with de novo variants in the gene encoding dynamin-1 (DNM1) is a severe debilitating disease with no pharmacological remedy. Like most genetic DEEs, the majority of DNM1 patients suffer from therapy-resistant seizures and comorbidities such...
Autores principales: | Aimiuwu, Osasumwen V., Fowler, Allison M., Sah, Megha, Teoh, Jia Jie, Kanber, Ayla, Pyne, Nettie K., Petri, Sabrina, Rosenthal-Weiss, Chana, Yang, Mu, Harper, Scott Q., Frankel, Wayne N. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Society of Gene & Cell Therapy
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7335739/ https://www.ncbi.nlm.nih.gov/pubmed/32353324 http://dx.doi.org/10.1016/j.ymthe.2020.04.007 |
Ejemplares similares
-
Overlaps, gaps, and complexities of mouse models of Developmental and Epileptic Encephalopathy
por: Wang, Wanqi, et al.
Publicado: (2020) -
Epileptic Encephalopathy
por: Specchio, Nicola, et al.
Publicado: (2012) -
Pre-clinical Safety and Off-Target Studies to Support Translation of AAV-Mediated RNAi Therapy for FSHD
por: Wallace, Lindsay M., et al.
Publicado: (2017) -
Altered Fast Synaptic Transmission in a Mouse Model of DNM1-Associated Developmental Epileptic Encephalopathy
por: McCabe, Matthew P., et al.
Publicado: (2021) -
Epileptic Encephalopathies: An Overview
por: Khan, Sonia, et al.
Publicado: (2012)